
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Omicron (B.1.1.529) variant of SARS‐CoV‐2: Concerns, challenges, and recent updates
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2336-2342
Open Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
Emerging SARS-CoV-2 Variants and Subvariants: Challenges and Opportunities in the Context of COVID-19 Pandemic
Smaranika Rahman, Md. Jamal Hossain, Zabun Nahar, et al.
Environmental Health Insights (2022) Vol. 16
Open Access | Times Cited: 24
Smaranika Rahman, Md. Jamal Hossain, Zabun Nahar, et al.
Environmental Health Insights (2022) Vol. 16
Open Access | Times Cited: 24
Risk evaluation and mitigation strategies for newly detected SARS‐CoV‐2 Omicron BF.7 subvariant: A brief report
Nazmunnahar Nazmunnahar, Iftekhar Ahmed, Md. Rabiul Islam
Health Science Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 13
Nazmunnahar Nazmunnahar, Iftekhar Ahmed, Md. Rabiul Islam
Health Science Reports (2023) Vol. 6, Iss. 3
Open Access | Times Cited: 13
The SARS‐CoV‐2 Omicron (B.1.1.529) variant and the re‐emergence of COVID‐19 in Europe: An alarm for Bangladesh
Md. Rabiul Islam
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 21
Md. Rabiul Islam
Health Science Reports (2022) Vol. 5, Iss. 2
Open Access | Times Cited: 21
Prevalence and associated factors for elevated fear and depressive symptoms among the private service holders in Bangladesh during the Covid‐19 pandemic: A cross‐sectional study
Md. Rabiul Islam, Zabun Nahar, Md. Sakhawat Hossain, et al.
Health Science Reports (2022) Vol. 5, Iss. 5
Open Access | Times Cited: 20
Md. Rabiul Islam, Zabun Nahar, Md. Sakhawat Hossain, et al.
Health Science Reports (2022) Vol. 5, Iss. 5
Open Access | Times Cited: 20
Increasing reinfections and decreasing effectiveness of COVID-19 vaccines urge the need for vaccine customization
Syed Masudur Rahman Dewan, Md. Rabiul Islam
Annals of Medicine and Surgery (2022) Vol. 84
Open Access | Times Cited: 20
Syed Masudur Rahman Dewan, Md. Rabiul Islam
Annals of Medicine and Surgery (2022) Vol. 84
Open Access | Times Cited: 20
Renewed global threat by the novel SARS-CoV-2 variants ‘XBB, BF.7, BQ.1, BA.2.75, BA.4.6’: A discussion
Ranjan K. Mohapatra, Ahmed Mahal, L. V. Simhachalam Kutikuppala, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 19
Ranjan K. Mohapatra, Ahmed Mahal, L. V. Simhachalam Kutikuppala, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 19
COVID-19 Vaccines' Protection Over Time and the Need for Booster Doses; a Systematic Review.
Omid Dadras, SeyedAhmad SeyedAlinaghi, Amirali Karimi, et al.
PubMed (2022) Vol. 10, Iss. 1, pp. e53-e53
Closed Access | Times Cited: 18
Omid Dadras, SeyedAhmad SeyedAlinaghi, Amirali Karimi, et al.
PubMed (2022) Vol. 10, Iss. 1, pp. e53-e53
Closed Access | Times Cited: 18
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11
Mingtao Liu, Hui Gan, Zhiman Liang, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 11
Reverse Zoonotic Transmission of SARS-CoV-2 and Monkeypox Virus: A Comprehensive Review
Chiranjib Chakraborty, Manojit Bhattacharya, Md. Aminul Islam, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 5, pp. 337-354
Closed Access | Times Cited: 3
Chiranjib Chakraborty, Manojit Bhattacharya, Md. Aminul Islam, et al.
The Journal of Microbiology (2024) Vol. 62, Iss. 5, pp. 337-354
Closed Access | Times Cited: 3
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
GeroScience (2022) Vol. 44, Iss. 5, pp. 2393-2425
Open Access | Times Cited: 17
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
GeroScience (2022) Vol. 44, Iss. 5, pp. 2393-2425
Open Access | Times Cited: 17
Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
Md. Rabiul Islam, Waheeda Nasreen, Ramisa Anjum, et al.
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 17
Md. Rabiul Islam, Waheeda Nasreen, Ramisa Anjum, et al.
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 17
SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert
Mohamad‐Hani Temsah, Fadi Aljamaan, Shuliweeh Alenezi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 16
Mohamad‐Hani Temsah, Fadi Aljamaan, Shuliweeh Alenezi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 16
Omicron B.1.1.529 subvariant: Brief evidence and future prospects
Ramadan Abdelmoez Farahat, Mohamed Baklola, Tungki Pratama Umar
Annals of Medicine and Surgery (2022) Vol. 83
Open Access | Times Cited: 16
Ramadan Abdelmoez Farahat, Mohamed Baklola, Tungki Pratama Umar
Annals of Medicine and Surgery (2022) Vol. 83
Open Access | Times Cited: 16
Cases of BA.2.75 and recent BA.2.75.2 subvariant of Omicron are increasing in India: Is it alarming at the global level?
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Annals of Medicine and Surgery (2022) Vol. 84
Open Access | Times Cited: 16
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Annals of Medicine and Surgery (2022) Vol. 84
Open Access | Times Cited: 16
Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacron Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021–Oct 2022)
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1933-1933
Open Access | Times Cited: 9
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1933-1933
Open Access | Times Cited: 9
Problematic internet use and depressive symptoms among the school‐going adolescents in Bangladesh during the COVID‐19 pandemic: A cross‐sectional study findings
Md. Rabiul Islam, Md. Ismail Tushar, Papia Sen Tultul, et al.
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 15
Md. Rabiul Islam, Md. Ismail Tushar, Papia Sen Tultul, et al.
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 15
Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic?
Kaixi Ding, Wei Jiang, Chunping Xiong, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 14
Kaixi Ding, Wei Jiang, Chunping Xiong, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 14
Emerging novel sub-lineage BA.2.75: The next dominant omicron variant?
Ranjan K. Mohapatra, Venkataramana Kandi, Snehasish Mishra, et al.
International Journal of Surgery (2022) Vol. 104, pp. 106835-106835
Closed Access | Times Cited: 14
Ranjan K. Mohapatra, Venkataramana Kandi, Snehasish Mishra, et al.
International Journal of Surgery (2022) Vol. 104, pp. 106835-106835
Closed Access | Times Cited: 14
Indian Biosimilars and Vaccines at Crossroads–Replicating the Success of Pharmagenerics
Sunita Panda, Puneet Kumar Singh, Snehasish Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
Sunita Panda, Puneet Kumar Singh, Snehasish Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 110-110
Open Access | Times Cited: 8
Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study
Youngsuk Ko, Victoria Mendoza, Renier Mendoza, et al.
Journal of Korean Medical Science (2022) Vol. 37, Iss. 26
Open Access | Times Cited: 12
Youngsuk Ko, Victoria Mendoza, Renier Mendoza, et al.
Journal of Korean Medical Science (2022) Vol. 37, Iss. 26
Open Access | Times Cited: 12
Recent outbreak of Marburg virus disease: Could it be a threat for global public health?
Md. Sohan, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan, et al.
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Md. Sohan, Mohammad Shahriar, Mohiuddin Ahmed Bhuiyan, et al.
Health Science Reports (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 12
Efficient inactivation of the contamination with pathogenic microorganisms by a combination of water spray and plasma-activated air
Li Guo, Pengyu Zhao, Yikang Jia, et al.
Journal of Hazardous Materials (2022) Vol. 446, pp. 130686-130686
Open Access | Times Cited: 12
Li Guo, Pengyu Zhao, Yikang Jia, et al.
Journal of Hazardous Materials (2022) Vol. 446, pp. 130686-130686
Open Access | Times Cited: 12
A bibliometric analysis of inflammatory bowel disease and COVID-19 researches
Fangfei Wang, Jinliang Xie, Huifang Xiong, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Fangfei Wang, Jinliang Xie, Huifang Xiong, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Risk Stratification Model for Severe COVID-19 Disease: A Retrospective Cohort Study
Miri Mizrahi Reuveni, Jennifer Kertes, Shirley Shapiro Ben David, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 767-767
Open Access | Times Cited: 7
Miri Mizrahi Reuveni, Jennifer Kertes, Shirley Shapiro Ben David, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 767-767
Open Access | Times Cited: 7
Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 61-63
Open Access | Times Cited: 7
Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 61-63
Open Access | Times Cited: 7